Terms: = Prostate cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
30 results:
1. CircTHSD4 promotes the malignancy and docetaxel (DTX) resistance in prostate cancer by regulating miR-203/hmga2 axis.
Xie J; Lu L; Zhang J; Li Q; Chen W
Oncol Res; 2024; 32(3):529-544. PubMed ID: 38361751
[TBL] [Abstract] [Full Text] [Related]
2. hsa_circ_0062019 promotes the proliferation, migration, and invasion of prostate cancer cells via the miR-195-5p/hmga2 axis.
Wang P; Zhang L; Yin S; Xu Y; Tai S; Zhang LI; Liang C
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(7):815-822. PubMed ID: 33978716
[TBL] [Abstract] [Full Text] [Related]
3. Long non‑coding RNA SChLAP1 regulates the proliferation of triple negative breast cancer cells via the miR‑524‑5p/hmga2 axis.
Bai X; Zhang S; Qiao J; Xing X; Li W; Zhang H; Xie J
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846810
[TBL] [Abstract] [Full Text] [Related]
4. An autopsy case of prostatic rhabdomyosarcoma with DICER1 hotspot mutation.
Miyama Y; Makise N; Miyakawa J; Kume H; Fukayama M; Ushiku T
Pathol Int; 2021 Jan; 71(1):102-108. PubMed ID: 33112496
[TBL] [Abstract] [Full Text] [Related]
5. LIN28B promotes the development of neuroendocrine prostate cancer.
Lovnicki J; Gan Y; Feng T; Li Y; Xie N; Ho CH; Lee AR; Chen X; Nappi L; Han B; Fazli L; Huang J; Gleave ME; Dong X
J Clin Invest; 2020 Oct; 130(10):5338-5348. PubMed ID: 32634132
[TBL] [Abstract] [Full Text] [Related]
6. cancer-driven IgG promotes the development of prostate cancer though the SOX2-CIgG pathway.
Qin C; Sheng Z; Huang X; Tang J; Liu Y; Xu T; Qiu X
Prostate; 2020 Sep; 80(13):1134-1144. PubMed ID: 32628304
[TBL] [Abstract] [Full Text] [Related]
7. MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting hmga2.
Huang WT; Zhang H; Jin Z; Li K; Hu C; Li ML; Situ J
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4710-4718. PubMed ID: 32432734
[TBL] [Abstract] [Full Text] [Related]
8. Programing Assembling/Releasing Multifunctional miRNA Nanomedicine to Treat prostate cancer.
Ma D; Liu H; Zhao P; Ye L; Zou H; Zhao X; Dai H; Kong X; Liu P
ACS Appl Mater Interfaces; 2020 Feb; 12(8):9032-9040. PubMed ID: 31986004
[TBL] [Abstract] [Full Text] [Related]
9. Paclitaxel-Potentiated Photodynamic Theranostics for Synergistic Tumor Ablation and Precise Anticancer Efficacy Monitoring.
Wang X; Tong J; He Z; Yang X; Meng F; Liang H; Zhang X; Luo L
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5476-5487. PubMed ID: 31910619
[TBL] [Abstract] [Full Text] [Related]
10. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene hmga2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through hmga2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract] [Full Text] [Related]
12. High mobility group A2 (hmga2) promotes EMT via MAPK pathway in prostate cancer.
Hawsawi O; Henderson V; Burton LJ; Dougan J; Nagappan P; Odero-Marah V
Biochem Biophys Res Commun; 2018 Sep; 504(1):196-202. PubMed ID: 30177390
[TBL] [Abstract] [Full Text] [Related]
13. A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy.
Wang L; Qu M; Huang S; Fu Y; Yang L; He S; Li L; Zhang Z; Lin Q; Zhang L
Nanoscale; 2018 Jul; 10(28):13673-13683. PubMed ID: 29987301
[TBL] [Abstract] [Full Text] [Related]
14. Silencing of hmga2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
[TBL] [Abstract] [Full Text] [Related]
15. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of hmga2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract] [Full Text] [Related]
17. IR-780 dye for near-infrared fluorescence imaging in prostate cancer.
Yi X; Yan F; Wang F; Qin W; Wu G; Yang X; Shao C; Chung LW; Yuan J
Med Sci Monit; 2015 Feb; 21():511-7. PubMed ID: 25686161
[TBL] [Abstract] [Full Text] [Related]
18. Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.
Schiraldi C; Zappavigna S; D' Agostino A; Porto S; Gaito O; Lusa S; Lamberti M; De Rosa M; De Rosa G; Caraglia M
Cancer Biol Ther; 2014; 15(11):1524-32. PubMed ID: 25482949
[TBL] [Abstract] [Full Text] [Related]
19. hmga2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation.
Müller MH; Drieschner N; Focken T; Bartnitzke S; Winter N; Klemke M; Bullerdiek J
Anticancer Res; 2013 Aug; 33(8):3069-78. PubMed ID: 23898062
[TBL] [Abstract] [Full Text] [Related]
20. miR-154 inhibits EMT by targeting hmga2 in prostate cancer cells.
Zhu C; Li J; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Wang M; Zhang Z; Qin C; Hua L; Yin C; Shao P
Mol Cell Biochem; 2013 Jul; 379(1-2):69-75. PubMed ID: 23591597
[TBL] [Abstract] [Full Text] [Related]
[Next]
